Frontlight ResearchEarly access
Trial site
The University of Texas MD Anderson Cancer Center - Texas Medical Center
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer3 trials
- Sarcoma3 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Bayer6 trials
- Blueprint Medicines Corporation1 trial
Running trials
Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Sarcoma2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026